Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, octubre 27
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
MAIA Biotechnology Inc
MAIA
AMEX
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$1.14
0.03
2.7%
Últ. Act.: Oct 27, 10:45 AM
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
MAIA Biotechnology Financials
MAIA Biotechnology (MAIA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
MAIA Biotechnology Q2 EPS $(0.13) Misses $(0.11) Estimate
MAIA Biotechnology (AMEX:MAIA) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 27.78 percent increase over losses of $(0.18) per share
Benzinga Newsdesk
PRO
MAIA Biotechnology Q1 EPS $(0.14) Beats $(0.18) Estimate
MAIA Biotechnology (AMEX:MAIA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.18) by 22.22 percent. This is a 12.5 percent increase over losses of $(0.16) per share from
Benzinga Newsdesk
PRO
MAIA Biotechnology Q4 EPS $(0.08) Beats $(0.13) Estimate
MAIA Biotechnology (AMEX:MAIA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.13) by 38.46 percent. This is a 33.33 percent increase over losses of $(0.12) per share from
Benzinga Newsdesk
PRO
MAIA Biotechnology Q2 EPS $(0.18) Beats $(0.24) Estimate
MAIA Biotechnology (AMEX:MAIA) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.24) by 25 percent. This is a 55 percent increase over losses of $(0.40) per share from the
Benzinga Newsdesk
PRO
MAIA Biotechnology Q3 EPS $(0.36) Beats $(0.38) Estimate
MAIA Biotechnology (AMEX:MAIA) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.38) by 5.26 percent. This is a 26.53 percent increase over losses of $(0.49) per share from
Benzinga Newsdesk
MAIA Biotechnology Cash Totaling ~$9.1M As Of June 30, 2023, Compared To $8.2M In Cash As Of June 30, 2022.
Happy Mohamed
